default author photo

Wuli Yang

Fudan University

Beijing West District Baiyun Load 10th

Shanghai, 100045

China

SCHOLARLY PAPERS

3

DOWNLOADS

134

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Microfluidic-Based Preparation of Plga Microspheres Facilitating Peptide Sustained-Release

Number of pages: 12 Posted: 21 Feb 2024
Sicong Tu, Shuting Mai, Dan Shu, Yuxin Huang, Zhihong Nie, Yang Wang and Wuli Yang
Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University and Fudan University
Downloads 48 (1,086,013)

Abstract:

Loading...

Biomaterials, Polymeric composites, Microfluidics, PLGA microspheres, peptide-loaded microspheres, drug release

2.

Second Near-Infrared Light-Activatable CO Nanogenerator for Enhanced Cancer Photo-Theranostics

Number of pages: 44 Posted: 15 Jul 2022
Xianxian Yao, Binru Yang, Chenzi Li, Qianjun He and Wuli Yang
Fudan University, Fudan University, Fudan University, Shenzhen University - Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging and Fudan University
Downloads 48 (1,086,013)

Abstract:

Loading...

carbon monoxide, NIR-II photothermal therapy, NIR-II photoacoustic imaging, Controlled release, gas therapy

3.

An Omics-Based Drug-Hifu Combination Therapy Discovery for Ferroptosis Treatment of Tnbc

Number of pages: 50 Posted: 31 Mar 2025
Ruizhe Xu, Xiaomin Su, Xifeng Qin, Yue Liu, Jiayi Wu, Xuejing Li, Ting Wang, Xingyue Gong, Boshu Ouyang, Huiwen Liu, Wuli Yang, Bo Zhang, Jun Zhang and zhiqing pang
Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Fudan University, Wuhan Union Hospital, Fudan University, Wuhan Union Hospital, Fudan University and Fudan University - Key Laboratory of Smart Drug Delivery, Ministry of Education
Downloads 38 (1,209,354)

Abstract:

Loading...

Combination therapy discovery, High intensity focused ultrasound, Ferroptosis therapy, Omics, Triple-negative breast cancer